Published in Blood Weekly, June 20th, 2002
While embryonic stem cells have been the subject of much recent attention and ethical debate, stem cells derived from adult bone marrow may prove to be even more suitable for therapeutic purposes, both as the key to blood vessel formation (angiogenesis) in tumors and as an alternative source of replaceable stem cells that can be used readily for fighting disease through organ regeneration and gene therapy.
The use of organ-specific stem cells from adult bone...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.